Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Department of Genetics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Head Neck Pathol. 2020 Dec;14(4):1080-1091. doi: 10.1007/s12105-020-01188-2. Epub 2020 Jun 6.
The microenvironment of oral cancer is highly dynamic and has been proved to affect tumor progression. Pericytes are blood vessels surrounding cells that have recently gained attention for their roles in vascular and cancer biology. The objective of the present study was to survey the scientific literature for conclusive evidence about whether pericytes are part of blood vessels in oral squamous cell carcinoma (OSCC) and their roles in the tumor microenvironment and clinical outcomes. A systematic electronic search was undertaken in Medline Ovid, PubMed, Web of Science, and Scopus. Eligibility criteria were: publications adopting in vivo models of OSCC that included pericyte detection and assessment by pericyte markers (e.g., α-smooth muscle actin, neuron-glial antigen 2 and platelet-derived growth factor receptor-β). The search yielded seven eligible studies (from 2008 to 2018). The markers most commonly used for pericyte detection were α-smooth muscle actin and neuron-glial antigen 2. The studies reviewed showed the presence of immature vessels exhibiting a reduction of pericyte coverage in OSCC and indicated that anti-cancer therapies could contribute to vessel normalization and pericyte regain. The pericyte population is significantly affected during OSCC development and cancer therapy. While these findings might suggest a role for pericytes in OSCC progression, the limited data available do not allow us to conclude whether they modify the tumor microenvironment and clinical outcome.
口腔癌的微环境高度动态,已被证明会影响肿瘤的进展。周细胞是围绕血管的细胞,最近因其在血管和癌症生物学中的作用而受到关注。本研究的目的是调查科学文献中关于周细胞是否是口腔鳞状细胞癌(OSCC)血管的一部分及其在肿瘤微环境和临床结局中的作用的确凿证据。在 Medline Ovid、PubMed、Web of Science 和 Scopus 中进行了系统的电子检索。纳入标准为:采用 OSCC 体内模型的出版物,包括周细胞检测和周细胞标志物(如α-平滑肌肌动蛋白、神经胶质抗原 2 和血小板衍生生长因子受体-β)评估。该检索共获得 7 项符合条件的研究(2008 年至 2018 年)。最常用于检测周细胞的标志物是α-平滑肌肌动蛋白和神经胶质抗原 2。综述的研究表明,OSCC 中存在成熟血管减少周细胞覆盖的不成熟血管,并表明抗癌治疗可能有助于血管正常化和周细胞恢复。周细胞群在 OSCC 发展和癌症治疗过程中受到显著影响。虽然这些发现可能表明周细胞在 OSCC 进展中发挥作用,但现有数据有限,无法得出它们是否改变肿瘤微环境和临床结局的结论。